Good news for pregnant women with asthma
Pregnant asthmatics who use inhaled steroids don't increase their risk of pregnancy-induced hypertension or preeclampsia, according to a recent nested case-control study from Canada.
Pregnant asthmatics who use inhaled steroids don't increase their risk of pregnancy-induced hypertension or preeclampsia, according to a recent nested case-control study from Canada.
The researchers included just over 3,500 women with asthma with a total of 4,593 pregnancies over a 10-year period. The adjusted odds ratios for women who used inhaled corticosteroids anytime from conception until pregnancy completion were 1.02 (95% CI; 0.77-1.34) for pregnancy-induced hypertension and 1.06 (0.74-1.53) for preeclampsia.
Oral corticosteroids were another story, however. They were linked to hypertension (OR: 1.57, 95% CI; 1.02-2.41), and researchers noticed a trend for an increase in preeclampsia (1.72, 0.98-3.02).
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
